Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.
about
Identifying microRNA/mRNA dysregulations in ovarian cancerIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisRegulating miRNA by natural agents as a new strategy for cancer treatmentInhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticlesComprehensive molecular characterization of clear cell renal cell carcinoma.microRNA-200b as a Switch for Inducible Adult AngiogenesisXB130-A Novel Adaptor Protein: Gene, Function, and Roles in TumorigenesismiR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injuryLinkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?Ensemble Methods for MiRNA Target Prediction from Expression Data.Epigenetic regulation of thyroid hormone receptor beta in renal cancer.Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural EffusionMicroRNAs: new insights into the pathogenesis of endodontic periapical disease.miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastomaEffects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene.Members of the microRNA-200 family are promising therapeutic targets in cancer.Robust multi-tissue gene panel for cancer detectionMiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders.Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.Joint analysis of miRNA and mRNA expression data.Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.XB130, a new adaptor protein, regulates expression of tumor suppressive microRNAs in cancer cells.Treatment-independent miRNA signature in blood of Wilms tumor patients.The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.The network of microRNAs, transcription factors, target genes and host genes in human renal cell carcinoma.miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancersCorrelated mRNAs and miRNAs from co-expression and regulatory networks affect porcine muscle and finally meat properties.Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.A microRNA signature associated with early recurrence in breast cancer.High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
P2860
Q21199589-C010F944-8102-4F61-9135-8DF51B4D2185Q26782613-5BE13B74-4EC5-4383-84BB-46FE15E20250Q26800055-CF2DEDB1-57DE-4289-B354-6A72F61964BDQ27026972-5E4A0A75-6901-482E-8FB5-6BE53CAF96ADQ27301841-32DD602F-2834-4736-A844-445448C6D31AQ27852374-F3DB31A1-585F-48A4-ABDB-62A205891796Q28080485-E61B4DFF-C282-4CA3-A9EF-2FA2BB32D70BQ28388570-7D836C1A-BE1C-4E3B-A2CE-154F2B9A2B92Q28395772-1F14356C-32EB-4C83-8829-FFC2216000E0Q30318519-1CB0634E-1E68-4215-926E-74B326564C9DQ30976943-FE31646C-D45A-4D45-9019-03B3D6743EA7Q31161553-EE10B133-FA9C-48E2-B196-7C011535AFD5Q33619253-E3A84088-3759-4464-9C34-6FBB9F1A140CQ33640951-BA8FBDA1-D747-4C4F-84A9-EDAE4CAB5491Q33751241-59F39613-259D-4ADA-94D3-F4A99466DD57Q33799049-D4909A49-5CC9-4B4A-91C0-9304F128324AQ33803485-F6DCE64E-5F5A-4FF9-A985-752FE7307DF2Q33833070-7D1AC311-089C-4E59-AB4D-9C3D38305E05Q33846551-9FF1E44A-4743-4B61-B1D9-DE9D14E9221CQ34004624-B2FA58CD-C17B-493C-89E9-CD98DFC837D6Q34017947-527E7AFF-52A0-4AB5-B91B-9FA2A5EE7420Q34018852-EADE613A-9D89-419E-BAE4-13E7C6E6907BQ34231578-5292B0CD-C919-411D-A7B8-16A75E1D4D3CQ34301646-E7993CCC-315A-41C7-93CF-84159B36C55EQ34306416-7541839D-5B10-4D53-89C3-A9D73862B9D6Q34335185-346C44F8-C11A-42B9-8E01-410943ADEB44Q34370023-20220E18-EBF0-423D-9B7A-F4154052AFD5Q34525363-A28F573F-F4ED-48D5-840B-FC7A5A435B30Q34582491-3CD593A7-6CF5-4A6A-A14C-3CA6FB55D060Q34623368-13C70FB8-BEF4-4478-B200-FB685430FBE2Q34894895-1B6DDF60-BDEE-4EA3-AB66-20A650A2AEE1Q35032590-4D86E207-7D39-4FDF-BCDF-421416DEE0E0Q35096116-7F9157FA-82A6-4DC5-9347-1A318FA864C0Q35121814-A7CBC83A-CF0E-4154-91A3-E1A08BCCF438Q35304761-11A622B3-5926-42FD-957B-FB36194CFC51Q35578981-09160D3C-E3A3-4870-A6AD-3F31DDE392D1Q35582977-CEB4DCF2-9257-47DB-9E5B-5E9D4365B790Q35621616-8896C98A-FA1F-4B75-B100-07CFCCC9E736Q35730683-5AE1FB96-C138-4BEF-9E06-88191A1D325EQ35750117-CDF05711-236B-4F6B-9083-0F231E4C781F
P2860
Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@ast
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@en
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@nl
type
label
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@ast
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@en
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@nl
prefLabel
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@ast
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@en
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Identifying mRNA targets of mi ...... ear cell Renal Cell Carcinoma.
@en
P2093
Alexandra Arreola
Angela R Brannon
Anupama R Reddy
Arnold J Levine
David Juan
Gyan V Bhanot
Huiqing Liu
Louis S Liou
Michael W Seiler
P2860
P2888
P356
10.1186/1752-0509-4-51
P577
2010-04-27T00:00:00Z
P5875
P6179
1029326294